Compare OIO & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OIO | GNLX |
|---|---|---|
| Founded | 1999 | 2001 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | Environmental Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.7M | 113.6M |
| IPO Year | N/A | 2022 |
| Metric | OIO | GNLX |
|---|---|---|
| Price | $2.11 | $2.98 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $17.25 |
| AVG Volume (30 Days) | 27.9K | ★ 153.0K |
| Earning Date | 05-01-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 9.47 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $8,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.50 | $2.29 |
| 52 Week High | $7.50 | $8.54 |
| Indicator | OIO | GNLX |
|---|---|---|
| Relative Strength Index (RSI) | 52.51 | 53.80 |
| Support Level | $1.60 | $2.51 |
| Resistance Level | $7.50 | $3.21 |
| Average True Range (ATR) | 0.21 | 0.13 |
| MACD | 0.04 | -0.01 |
| Stochastic Oscillator | 61.28 | 54.14 |
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.